Published on September 9, 2015
Cancer cachexia, weakness and wasting of the body due to cancer, can be a serious issue for lung cancer patients. And medical experts, such as Dr. Phillip Bonomi at Rush Medical Center in Chicago, Illinois, talked with Andrew Schorr on location at the World Conference on Lung Cancer (WCLC) in Denver, Colorado about the newest FDA-approved drug, anamorelin. Anamorelin shows promise in preventing weight loss, increasing muscle mass, and in some studies, even showed indications of improving fatigue symptoms. Watch as Dr. Bonomi expounds on this extremely important breakthrough for lung cancer patients.